Orzaks İlaç Sets IPO Schedule: June 29 – July 1

Orzaks İlaç will conduct an initial public offering between June 29 and July 1, offering shares at a fixed price of 69 TL per share. The company plans to raise a total of 3.62 billion TL in capital during this process. The fixed‑price structure aims to eliminate price uncertainty for investors, providing a more transparent investment environment. The 3.62 billion TL capital raise will serve as a significant funding source to support the company’s research and development activities and expand its production capacity. Amid increasing competition in the pharmaceutical sector and rising R&D investments, Orzaks İlaç’s IPO is viewed as a critical step in the company’s long‑term growth strategy. Investors can shape their decisions by considering the company’s financial performance and sectoral trends. This is not investment advice.